Lipoxygenase inhibitors block PDGF-induced mitogenesis : a MAPK-independent mechanism that blocks fos and egr .

Beno DW ; Mullen J ; Davis BH

Department of Medicine , University of Chicago , Illinois 60637 .

Am J Physiol 268 : C604-10 ( 1995)

Abstract
Hepatic Ito cells proliferate during liver injury and fibrogenesis . Platelet-derived growth factor ( PDGF)-induced [ 3H]thymidine incorporation was studied as Ito cells express the PDGF receptor after injury and activation . Pretreatment with either the nonspecific lipoxygenase inhibitor ( nordihydroguaiaretic acid ) or specific inhibitors of 5-lipoxygenase ( SC-41661 and ICI-230487 ) inhibited PDGF-induced mitogenesis . Ito cells predominantly produce the leukotriene ( LT ) C4 >> ; LTB4 . The PDGF-induced signal transduction cascade was studied to determine the potential mechanism of action of the lipoxygenase inhibitors . It was found that PDGF receptor abundance and receptor activation were not altered by lipoxygenase inhibition , suggesting that a postreceptor mechanism was involved . The two-key cytoplasmic serine-threonine kinases Raf and MAPK ( mitogen-activated protein kinase ) , which are induced by PDGF and transmit the signal to the nucleus , were also not altered . Because Raf and MAPK can independently induce nuclear signaling , this suggests that the mechanism of action lies parallel or distal to these secondary messengers . Lipoxygenase inhibition did result in the suppression of PDGF-induced fos and egr expression . Collectively , this work suggests that lipoxygenase inhibition leads to the suppression of mitogenesis in part by disrupting the nuclear signaling that is required for protooncogene transcription at a step distal or parallel to MAPK activation .